Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:29 PM
Ignite Modification Date:
2025-12-24 @ 5:29 PM
NCT ID:
NCT04705168
Eligibility Criteria:
Inclusion Criteria:
* Adult patients (\> 30 years of age) at the time of the initial study visit.
* Patients displaying a phenotype that consists of ≥ 100 nevi on the entire cutaneous surface and at least three large acquired nevi (LAN) \> 5 mm in diameter. These patients have "atypical mole syndrome", which is a high-risk nevus phenotype and the target patient population in this study.
* Patients with at least three clinically stable nevi between 5 and 20 mm in diameter.
* Patients (or LAR) who are able to provide informed consent.
* Patients with previous total body photography images taken at least 3 years prior
Exclusion Criteria:
* Patients without at least three clinically stable nevi between 5 and 20 mm in diameter.
* Patients with any electronic implantable devices.
* Patients who are pregnant (verbally confirmed with the participant).
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
30 Years
Study:
NCT04705168
Study Brief:
Protocol Section:
NCT04705168